MND isn’t incurable, it’s underfunded ...

Rebuilding the clinical trials landscape in the UK ...

Women’s health issues have historically been under-researched, marginalised and underserved. This systemic neglect has led to ...

What is, exactly, going on with the NHS at the moment? You could be forgiven for thinking the fireworks of this summer’s ...

2025 is not just another year in pharma – it’s a turning point. The industry is riding a wave of scientific breakthroughs, regulatory agility and patient-centric innovation that’s reshaping the very ...

More than half the UK population will experience a skin condition at some point in their lives. For many, these are debilitating diseases that can impact quality of life, mental health and daily ...

The Christie NHS Foundation Trust has completed a four-month digital transformation project using Netcall’s Liberty Spark to ...

Heidelberg Pharma has reported encouraging progress in its phase 2/2a trial of HDP-101 (INN: pamlectabart tismanitin), its ...

Theolytics has named Matilde Saggese as its new Chief Medical Officer, as the Oxford-based biotech company accelerates ...

Symeres has appointed Gabriella Gentile as Chief Operating Officer, strengthening its executive team as the company pursues ...

Santhera Pharmaceuticals has announced positive topline results from a long-term analysis of AGAMREE (vamorolone) in patients ...

Sonoma Biotherapeutics has announced positive interim results from its ongoing phase 1 Regulate-RA trial evaluating ...